Current progress in chimeric antigen receptor-modified T cells for the treatment of metastatic breast cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Current progress in chimeric antigen receptor-modified T cells for the treatment of metastatic breast cancer

Published:2023-06 Issue: Volume:162 Page:114648
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Yin Li,Chen Gui-lai,Xiang Zhuo,Liu Yu-lin,Li Xing-yu,Bi Jing-wang,Wang Qiang^ORCID

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference209 articles.

1. Cancer statistics, 2022;Siegel;CA Cancer J. Clin.,2022

2. Breast cancer as a systemic disease: a view of metastasis;Redig;J. Intern Med.,2013

3. Breast carcinoma: from initial tumor cell detachment to settlement at secondary sites;Melzer;Biomed. Res Int,2017

4. The clinical course of bone metastases from breast cancer;Coleman;Br. J. Cancer,1987

5. Genes that mediate breast cancer metastasis to lung;Minn;Nature,2005

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current progress in chimeric antigen receptor T‐cell therapy for malignant tumors;MedComm – Future Medicine;2024-05-13

2. CAR-based immunotherapy for breast cancer: peculiarities, ongoing investigations, and future strategies;Frontiers in Immunology;2024-04-12

3. Recent advances in targeted strategies for triple-negative breast cancer;Journal of Hematology & Oncology;2023-08-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP